Patent: 6,100,294
✉ Email this page to a colleague
Summary for Patent: 6,100,294
| Title: | Cyclic ether vitamin D3 compounds, 1.alpha.(OH) 3-epi-vitamin D3 compounds and uses thereof |
| Abstract: | Novel cyclic ether vitamin D3 compounds having a cyclic ether side chain are disclosed. These compounds were first identified as metabolites of 3-epi vitamin D3 produced via a tissue-specific metabolic pathway which catalyzes the formation of a cyclic ether structure. Also disclosed are 1.alpha.(OH) 3-epi vitamin D3 compounds, which are produced via the epimerization of a 3-.beta.-hydroxyl group of 1.alpha.(OH) vitamin D3 precursor in vivo. The vitamin D3 compounds of the present invention can be used as substitutes for natural and synthetic vitamin D3 compounds. |
| Inventor(s): | Reddy; Satayanarayana G. (Barrington, RI) |
| Assignee: | Women and Infants Hospital (Providence, RI) |
| Application Number: | 09/079,942 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,100,294
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2017-05-16 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
